DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,943,534 | +8.5% | 48,140 | +4.9% | 0.67% | +21.1% |
| Q2 2023 | $11,010,960 | -9.0% | 45,879 | -4.4% | 0.55% | +1.1% |
| Q1 2023 | $12,100,692 | -0.1% | 48,011 | +5.3% | 0.54% | +2.3% |
| Q4 2022 | $12,106,868 | +13.7% | 45,614 | +10.7% | 0.53% | +4.3% |
| Q3 2022 | $10,646,000 | +1.2% | 41,219 | -0.6% | 0.51% | +5.8% |
| Q2 2022 | $10,517,000 | +13.5% | 41,483 | +31.3% | 0.48% | +33.8% |
| Q1 2022 | $9,265,000 | -26.5% | 31,586 | -17.5% | 0.36% | -11.1% |
| Q4 2021 | $12,597,000 | +9.0% | 38,288 | +0.9% | 0.41% | +2.8% |
| Q3 2021 | $11,555,000 | +12.4% | 37,956 | -0.9% | 0.40% | +19.7% |
| Q2 2021 | $10,281,000 | +20.9% | 38,309 | +1.4% | 0.33% | +17.0% |
| Q1 2021 | $8,502,000 | +2.9% | 37,774 | +1.6% | 0.28% | +8.5% |
| Q4 2020 | $8,260,000 | -11.1% | 37,183 | -13.8% | 0.26% | -30.7% |
| Q3 2020 | $9,290,000 | -21.8% | 43,141 | -35.8% | 0.38% | -21.7% |
| Q2 2020 | $11,880,000 | -15.1% | 67,181 | -33.5% | 0.48% | -27.2% |
| Q1 2020 | $13,986,000 | -52.6% | 101,046 | -47.4% | 0.66% | -21.3% |
| Q4 2019 | $29,478,000 | -8.3% | 192,066 | -13.7% | 0.84% | -8.0% |
| Q3 2019 | $32,136,000 | -10.6% | 222,500 | -11.6% | 0.91% | -7.8% |
| Q2 2019 | $35,956,000 | -41.3% | 251,580 | -45.8% | 0.99% | -32.4% |
| Q1 2019 | $61,273,000 | +10.5% | 464,121 | -13.7% | 1.46% | +4.1% |
| Q4 2018 | $55,452,000 | -46.0% | 537,745 | -43.1% | 1.40% | -28.7% |
| Q3 2018 | $102,757,000 | +18.9% | 945,678 | +8.0% | 1.97% | +26.7% |
| Q2 2018 | $86,430,000 | -8.7% | 875,861 | -9.4% | 1.55% | +0.3% |
| Q1 2018 | $94,668,000 | +14.0% | 966,884 | +8.1% | 1.55% | +16.0% |
| Q4 2017 | $83,010,000 | -18.6% | 894,313 | -24.8% | 1.33% | -18.5% |
| Q3 2017 | $102,034,000 | +7.7% | 1,189,484 | +6.0% | 1.64% | +13.0% |
| Q2 2017 | $94,697,000 | +98.5% | 1,122,139 | +101.2% | 1.45% | +99.0% |
| Q1 2017 | $47,697,000 | +7.1% | 557,669 | -2.5% | 0.73% | +10.1% |
| Q4 2016 | $44,529,000 | -7.8% | 572,064 | -7.2% | 0.66% | -10.9% |
| Q3 2016 | $48,309,000 | -37.2% | 616,267 | -19.0% | 0.74% | -40.2% |
| Q2 2016 | $76,873,000 | +9.9% | 761,121 | +3.2% | 1.24% | +12.7% |
| Q1 2016 | $69,978,000 | +74.8% | 737,695 | +71.2% | 1.10% | +82.9% |
| Q4 2015 | $40,028,000 | -13.1% | 430,970 | -20.3% | 0.60% | -3.2% |
| Q3 2015 | $46,078,000 | +4.7% | 540,755 | +5.2% | 0.62% | +14.3% |
| Q2 2015 | $44,004,000 | -25.0% | 514,130 | -25.6% | 0.54% | -17.5% |
| Q1 2015 | $58,650,000 | -10.4% | 690,815 | -9.6% | 0.66% | -1.9% |
| Q4 2014 | $65,462,000 | +11.3% | 763,765 | -1.4% | 0.67% | +14.5% |
| Q3 2014 | $58,826,000 | +67.7% | 774,226 | +73.8% | 0.59% | +108.2% |
| Q2 2014 | $35,069,000 | – | 445,430 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |